Oral Chemotherapy Application in Elderly Patients With Diffuse Large B-Cell Lymphoma: An Alternative Regimen in Retrospective Analysis

BACKGROUND: A combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is considered the standard treatment for diffuse large B-cell lymphoma (DLBCL). However, no standard treatment has been established for older patients (age ≥ 75 years). This study retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Pi-Han, Kuo, Ching-Yuan, Ma, Ming-Chun, Liao, Chin-Kai, Pei, Sung-Nan, Wang, Ming-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635798/
https://www.ncbi.nlm.nih.gov/pubmed/36406829
http://dx.doi.org/10.14740/jh1054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635798/
https://www.ncbi.nlm.nih.gov/pubmed/36406829
http://dx.doi.org/10.14740/jh1054

Ejemplares similares